Abstract
Considering the paucity of data relating erythropoiesis-stimulating agent (ESA) use to ovarian cancer survival, our objective was to evaluate the effect of ESA as used for the treatment of chemotherapy-induced anemia (CIA) on survival in ovarian cancer patients. A multi-institution retrospective chart review was performed on ovarian cancer patients. Data collection included patient demographic, surgicopathologic, chemotherapy, ESA, and survival data. Patients were stratified by ever-use of ESA and were compared using appropriate statistical methods. A total of 581 patients were eligible for analysis with 39% (n = 229) patients with ever-use of ESA (ESA-YES) and 61% (n = 352) never-use ESA (ESA-NO). Mean age was 60.4 years with most patients having stage IIIC (60%) of papillary serous histological diagnosis (64%) with an optimal cytoreduction (67%). Median follow-up for the cohort was 27 months. Both ESA-YES and ESA-NO groups were similar regarding age, body mass index, race, stage, histological diagnosis, and debulking status. Compared with the ESA-NO group, ESA-YES patients were significantly more likely to experience recurrence (56% vs 80%, P < 0.001) and death (46% vs 59%, P = 0.002). Kaplan-Meier curves demonstrated a signi...Continue Reading
References
May 29, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C OberhoffH Zwierzina
Oct 21, 2000·The Oncologist·G A CurtN J Vogelzang
Aug 16, 2001·Journal of the National Cancer Institute·J SeidenfeldN Aronson
Apr 16, 2002·British Journal of Cancer·M LindD Wild
Jul 25, 2003·British Journal of Haematology·Michael HedenusUNKNOWN Darbepoetin Alfa 20000161 Study Group
Oct 25, 2003·Lancet·Michael HenkeHermann Frommhold
Aug 25, 2004·Cancer Treatment Reviews·Erminia FerrarioEmilio Bajetta
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian Leyland-JonesEls Vercammen
Jan 13, 2006·Gynecologic Oncology·Ashley S CaseMack N Barnes
May 18, 2006·Journal of the National Cancer Institute·Julia BohliusAndreas Engert
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R WrightMark N Levine
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Douglas RizzoUNKNOWN American Society of Hematology
Mar 4, 2008·JAMA : the Journal of the American Medical Association·Charles L BennettMichael Henke
Jul 17, 2008·Supportive Cancer Therapy·José ChangKara Lee McWatters
May 2, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marcello TonelliScott Klarenbach
May 5, 2009·Lancet·Julia BohliusAndreas Engert
Jun 19, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Zachary Crouch, Evelyn R Hermes DeSantis
Citations
May 3, 2014·International Journal of Nanomedicine·Efthymia-Iliana MatthaiouYadollah Omidi
Oct 29, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Insiya B PoonawallaXianglin L Du
Sep 30, 2015·Biofabrication·Yanfeng LuJae-Won Choi